drugset / Trial / NCT02955719

CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia

NCT02955719

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Age remains the single most significant risk factor for developing dementia, particularly Alzheimer's dementia (AD). Given the rate at which Canada's population is aging, the quest to determine modifiable risk factors, whether by prevention, earlier detection, or an ability to slow the rate of decline, is a key priority in health care. Primary care is likely to play a pivotal role in this initiative. Collaborative mental health care between primary care providers and mental health clinicians has been demonstrated to be effective at the patient and system levels. Thus, the overall goal of this project is to assess impact and feasibility of implementing a collaborative care evidence-based Integrated Care Pathway (ICP) in addressing three potentially reversible risk factors at high risk for developing AD: anxiety, depression, or mild cognitive impairment (MCI).

Timeline

Start
2016-03-30
Primary completion
2020-07-16
Completion
2020-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule
Subject Venlafaxine Small molecule